Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Task Force To Develop Approaches To Nanotechnology In Drugs, Foods

This article was originally published in The Tan Sheet

Executive Summary

FDA's Nanotechnology Task Force will identify policy gaps related to the use of nanotechnology particles to evaluate possible adverse health effects from products that contain the materials, the agency said

You may also be interested in...



Nanotech grant

The National Institutes of Health awards a $1.6 million Research Project Grant to Luna Innovations to investigate the efficacy of fullerene-based nanomedicines in treating allergies and other inflammatory conditions, according to a July 22 release. Roanoke, Va.-based Luna says it modified fullerenes, a class of carbon molecules, to amplify the immune response in cells and "block the noxious effects of allergies." With the NIH funding, the health science developer intends to further explore systemic, cellular and molecular responses to fullerenes through in vivo and in vitro tests. NIH awarded the grant through its National Institute of General Medical Sciences and participates in the National Nanotechnology Initiative to evaluate nanomaterials (1"The Tan Sheet" Aug. 14, 2006, p. 7)...

Nanotech grant

The National Institutes of Health awards a $1.6 million Research Project Grant to Luna Innovations to investigate the efficacy of fullerene-based nanomedicines in treating allergies and other inflammatory conditions, according to a July 22 release. Roanoke, Va.-based Luna says it modified fullerenes, a class of carbon molecules, to amplify the immune response in cells and "block the noxious effects of allergies." With the NIH funding, the health science developer intends to further explore systemic, cellular and molecular responses to fullerenes through in vivo and in vitro tests. NIH awarded the grant through its National Institute of General Medical Sciences and participates in the National Nanotechnology Initiative to evaluate nanomaterials (1"The Tan Sheet" Aug. 14, 2006, p. 7)...

Nanotech grant

The National Institutes of Health awards a $1.6 million Research Project Grant to Luna Innovations to investigate the efficacy of fullerene-based nanomedicines in treating allergies and other inflammatory conditions, according to a July 22 release. Roanoke, Va.-based Luna says it modified fullerenes, a class of carbon molecules, to amplify the immune response in cells and "block the noxious effects of allergies." With the NIH funding, the health science developer intends to further explore systemic, cellular and molecular responses to fullerenes through in vivo and in vitro tests. NIH awarded the grant through its National Institute of General Medical Sciences and participates in the National Nanotechnology Initiative to evaluate nanomaterials (1"The Tan Sheet" Aug. 14, 2006, p. 7)...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel